1036 related articles for article (PubMed ID: 27618563)
1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes.
Teras LR; DeSantis CE; Cerhan JR; Morton LM; Jemal A; Flowers CR
CA Cancer J Clin; 2016 Nov; 66(6):443-459. PubMed ID: 27618563
[TBL] [Abstract][Full Text] [Related]
2. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM
Int J Cancer; 2014 Nov; 135(9):2146-56. PubMed ID: 24639369
[TBL] [Abstract][Full Text] [Related]
3. Subtype distribution of lymphomas in South of Iran, analysis of 1085 cases based on World Health Organization classification.
Monabati A; Safaei A; Noori S; Mokhtari M; Vahedi A
Ann Hematol; 2016 Mar; 95(4):613-8. PubMed ID: 26754635
[TBL] [Abstract][Full Text] [Related]
4. Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.
Yoon SO; Suh C; Lee DH; Chi HS; Park CJ; Jang SS; Shin HR; Park BH; Huh J
Am J Hematol; 2010 Oct; 85(10):760-4. PubMed ID: 20806229
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
6. Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000-2018.
Morton LM; Curtis RE; Linet MS; Schonfeld SJ; Advani PG; Dalal NH; Sasse EC; Dores GM
EClinicalMedicine; 2023 Jul; 61():102060. PubMed ID: 37457112
[TBL] [Abstract][Full Text] [Related]
7. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS
Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944
[TBL] [Abstract][Full Text] [Related]
8. Nationwide Statistical Analysis of Lymphoid Malignancies in Korea.
Lee H; Park HJ; Park EH; Ju HY; Oh CM; Kong HJ; Jung KW; Park BK; Lee E; Eom HS; Won YJ
Cancer Res Treat; 2018 Jan; 50(1):222-238. PubMed ID: 28361523
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.
Morton LM; Wang SS; Devesa SS; Hartge P; Weisenburger DD; Linet MS
Blood; 2006 Jan; 107(1):265-76. PubMed ID: 16150940
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
11. Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data.
Ye X; Mahmud S; Skrabek P; Lix L; Johnston JB
BMJ Open; 2017 Jul; 7(7):e015106. PubMed ID: 28716788
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
13. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
Lee MY; Tan TD; Feng AC; Liu MC
Am J Hematol; 2006 Aug; 81(8):568-75. PubMed ID: 16823825
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
16. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
17. Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries.
Naresh KN; Advani S; Adde M; Aziz Z; Banavali S; Bhatia K; Belgaumi A; Ezzat A; Khaled H; Mokhtar N; Norton A; Rohatiner A; Sagar TG; Taciyliz N; Temmim L; Venkatesh C; Yan Tang J; Magrath I
Blood Cells Mol Dis; 2004; 33(3):330-7. PubMed ID: 15528153
[TBL] [Abstract][Full Text] [Related]
18. Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure.
van Leeuwen MT; Turner JJ; Falster MO; Meagher NS; Joske DJ; Grulich AE; Giles GG; Vajdic CM
Int J Cancer; 2013 Aug; 133(4):944-51. PubMed ID: 23382012
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network.
Lamb M; Painter D; Howell D; Barrans S; Cargo C; de Tute R; Tooze R; Burton C; Patmore R; Roman E; Smith A
Cancer Epidemiol; 2024 Feb; 88():102513. PubMed ID: 38160571
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]